filings.toolsItem 5. OTHER INFORMATION
3K characters. Original on sec.gov · Markdown
Item 5. OTHER INFORMATION
Securities Trading Plans of Executive Officers and Directors
Transactions in our securities by our executive officers and directors are required to be made in accordance with our insider trading policy, which, among other things, requires that the transactions be in accordance with applicable U.S. federal securities laws that prohibit trading while in possession of material nonpublic information. Our insider trading policy permits our executive officers and directors to enter into trading plans in accordance with Rule 10b5-1.
The following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted by our executive officers and directors during the third quarter of 2025, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), referred to as Rule 10b5-1 trading plans.
| Name and Title | Action | Date of Adoption of Rule 10b5-1 Trading Plan | Scheduled Expiration Date of Rule 10b5-1 Trading Plan (1) | Aggregate Number of Securities/Dollar Value to be Purchased or Sold | ||||||||||||||||||||||
| Katherine H. Ramundo, Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary | Adoption | 8/12/2025 | 1/30/2026 | Sale of up to 18,000 ordinary shares | ||||||||||||||||||||||
| Varun Laroyia, Executive Vice President and Chief Financial Officer | Adoption | 9/4/2025 | 4/30/2026 | Sale of up to 5,359 ordinary shares | ||||||||||||||||||||||
| Sean O. Mahoney, Director | Adoption | 9/5/2025 | 12/31/2025 | Sale of up to 7,881 ordinary shares |
(1)In each case, a trading plan may also expire on such earlier dates as all transactions under the trading plan are completed.
On September 18, 2025 , Allan J. Brazier's trading plan, dated August 15, 2025, intended to satisfy Rule 10b5-1(c) to sell up to 7,539 ordinary shares between November 17, 2025 and February 27, 2026, subject to certain conditions, terminated by its terms, under which no shares were ultimately sold.
During the third quarter of 2025, no executive officer or director of the Company adopted, modified or terminated any non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K).
Previous: Item 1A. RISK FACTORS · Next: Item 6. EXHIBITS